Potassium Carbonate → (S)-6-[1-(2-benzyloxyethyl)piperidin-3-yloxy]-2H-isoquinolin-1-one
Reaction equation
[CH2:1]([O:8][CH2:9][CH2:10]Br)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[NH:12]1[CH2:17][CH2:16][CH2:15][C@H:14]([O:18][C:19]2[CH:20]=[C:21]3[C:26](=[CH:27][CH:28]=2)[C:25](=[O:29])[NH:24][CH:23]=[CH:22]3)[CH2:13]1.C(=O)([O-])[O-].[K+].[K+]>CN(C)C=O>[CH2:1]([O:8][CH2:9][CH2:10][N:12]1[CH2:17][CH2:16][CH2:15][C@H:14]([O:18][C:19]2[CH:20]=[C:21]3[C:26](=[CH:27][CH:28]=2)[C:25](=[O:29])[NH:24][CH:23]=[CH:22]3)[CH2:13]1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1Participants
5
Procedure
2-Benzyloxyethyl bromide (1 mol) was added to a suspension of (S)-6-(piperidin-3-yloxy)-2H-isoquinolin-1-one (30 mg, 0.12 mmol) and potassium carbonate (70mg, 4.2 mol) in N, N-dimethylformamide (500 μl) and shaken for 17 hours. The reaction was quenched with hydrochloric acid (2M) and methanol and passed down an SCX cartridge. The products were purified by preparative HPLC under basic conditions. The clean products were isolated by evaporation under reduced pressure to afford (S)-6-[1-(2-benzyloxyethyl)piperidin-3-yloxy]-2H-isoquinolin-1-one: El-MS: m/z=379.4[M+H]+.
Workup
- customThe reaction was quenched with hydrochloric acid (2M) and methanol
- customThe products were purified by preparative HPLC under basic conditions
- customThe clean products were isolated by evaporation under reduced pressure
Sources & evidence
- ORD record
- ord-51ed400adef14acc9433f2a4f002242d
- Source dataset
- uspto-grants-2009_11
- Patent number
- US07618985B2
Reaction notes
Loading…